| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |